Tarsus Pharmaceuticals, Inc. - Common Stock (TARS)
47.10
-0.05 (-0.11%)
Tarsus Pharmaceuticals Inc is a biopharmaceutical company focused on developing innovative therapies for unmet medical needs in the field of ocular health
The company specializes in the discovery and commercialization of treatments aimed at addressing various eye conditions, with an emphasis on conditions that significantly impact the quality of life. Through its research and development efforts, Tarsus is working to provide patients with effective solutions that enhance vision and overall eye health, leveraging advanced scientific approaches to create novel therapeutic options.